Raul Rodriguez
Algemeen Directeur bij RIGEL PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 30-04-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Gregg Lapointe | M | 65 | 7 jaar | |
Walter Moos | M | 69 | 27 jaar | |
Jane Wasman | F | 67 | 5 jaar | |
Kamil Ali-Jackson | F | 65 | 3 jaar | |
Raymond Furey | M | 56 | 2 jaar | |
Alison Hannah | M | 63 | 3 jaar | |
Brian Kotzin | M | 74 | 7 jaar | |
Dean Schorno | M | 61 | 6 jaar | |
Joseph Lasaga | M | - | 26 jaar | |
Esteban S. Masuda | M | - | 8 jaar | |
Julie Patel | F | - | 2 jaar | |
David Santos | M | 61 | 4 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Donald G. Payan | M | 75 | 20 jaar | |
Dolly Vance | F | 59 | 22 jaar | |
James M. Gower | M | 75 | 18 jaar | |
Gary Lyons | M | 73 | 19 jaar | |
Bradford Goodwin | M | 69 | - | |
Daniel B. Magilavy | M | - | - | |
Jodi A. Sievers | F | - | 1 jaar | |
Stephen Sherwin | M | 75 | 17 jaar | |
James Welch | M | 66 | 7 jaar | |
Hollings Renton | M | 77 | 10 jaar | |
David Burke | M | - | 3 jaar | |
Ryan Maynard | M | 54 | 16 jaar | |
Bruce A. Leicher | M | 68 |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | - |
Roberto Pedro Rosenkranz | M | 74 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 1 jaar |
Nelson Cabatuan | M | 47 | 12 jaar | |
Peter S. Ringrose | M | 78 | 14 jaar | |
Keith Katkin | M | 52 | 7 jaar | |
Rajinder Singh | M | - | 18 jaar | |
Wolfgang Dummer | M | 58 | 4 jaar | |
Francesco Parlati | M | 55 | 2 jaar | |
Giovanna Matthews | F | - | 3 jaar | |
Michael Crockett | M | - |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | - |
Lily Cheung | F | 51 | 3 jaar | |
Dana Pizzuti | M | 68 | 2 jaar | |
Eldon Mayer | M | 62 | 3 jaar | |
Stacy Markel | F | 59 | 1 jaar | |
Donald B. Rice | M | 83 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 6 jaar |
Anne-Marie S. Duliege | M | 64 | 3 jaar | |
Garry Nolan | M | 63 | 6 jaar | |
Mark K. Bennett | M | 65 | 4 jaar | |
Susan Molineaux | M | 70 | 3 jaar | |
Arlene Morris | F | 72 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 3 jaar |
George F. Schreiner | M | 74 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 9 jaar |
Alan Frazier | M | 72 | 9 jaar | |
Elliott B. Grossbard | M | 76 | 14 jaar | |
Lee L. Rubin | M | 73 |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | 3 jaar |
Jean Deleage | M | 83 | 14 jaar | |
Nicholas Simon | M | 67 | - | |
Dennis J. Henner | M | 72 | - | |
Robin D. G. Cooper | M | 85 | - | |
Garry Nolan | M | - | 6 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 53 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Raul Rodriguez
- Persoonlijk netwerk